KIRSTEN DEKOSTER: Open Payments
NPI 1447036173 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,138 in 107 payments from 19 companies in 2025. Trend: 2023 $150 · 2024 $2,980 · 2025 $4,138
Food & beverage: $3,939Education: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $599 |
| Regeneron Healthcare Solutions, Inc. | 10 | $434 |
| GENZYME CORPORATION | 8 | $406 |
| UCB, Inc. | 8 | $385 |
| Novartis Pharmaceuticals Corporation | 14 | $323 |
| Janssen Biotech, Inc. | 7 | $319 |
| Lilly USA, LLC | 6 | $307 |
| Arcutis Biotherapeutics, Inc. | 4 | $232 |
| PFIZER INC. | 4 | $165 |
| Galderma Laboratories, L.P. | 7 | $162 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, EBGLYSS, Zoryve, CIBINQO, COSENTYX.
Industry payments across CO — which companies pay providers there.
